Escolar Documentos
Profissional Documentos
Cultura Documentos
(11) 3848.3333
formula-ativa.com.br
@formulaativa online@formula-ativa.com.br
Inúmeros ensaios clínicos demonstram que o consumo de probióticos proporciona melhora significa-
tivamente a função pulmonar, fluxo expiratório noturno e os escores de asma e rinite alérgica. Além
disso, proporcionam redução significativa na produção de citocinas inflamatórias como TNF-α, IFN -
, IL-12 e IL-13.
A patogênese de doenças alérgicas, como a rinite, tem sido descrita como o desequilíbrio das células
Th1/Th2.
Os probióticos inibem esta patologia por suprimir a resposta Th2. As interleucinas IL-4, IL-5 e IL-13
são as citocinas representativas liberadas por células Th2, que são reprimidas pelos probióticos.
Além disso, eles aumentam o nível de IL-10 e o TGF-β através das células T regulatórias em doenças
alérgicas.
(11) 3848.3333
formula-ativa.com.br
@formulaativa online@formula-ativa.com.br
Estudos clínicos demonstraram que a suplementação de certas cepas probióticas, como terapia com-
plementar é eficaz no tratamento de doenças alérgicas respiratórias como asma e rinite.
Saccharomyces boulardi................................250mg
GliSODin®.........................................................100mg
(11) 3848.3333
formula-ativa.com.br
@formulaativa online@formula-ativa.com.br
(11) 3848.3333
formula-ativa.com.br
@formulaativa online@formula-ativa.com.br
Referências consultadas:
Fiocchi A, et al. World Allergy Organization-McMaster University Guidelines for Allergic Disease Prevention (GLAD-P): Probiotics. World
Allergy Organization Journal (2015) 8:4.
Das RR, et al. Probiotics as additives on therapy in allergic airway diseases: a systematic review of benefits and risks. Biomed Res Int.
2013;2013:231979.
Yang G, Liu ZQ, Yang PC. Treatment of Allergic Rhinitis with Probiotics: An Alternative Approach. N Am J Med Sci. Aug 2013; 5(8): 465–468.
Kim HJ, et al. Clinical efficacy and mechanism of probiotics in allergic diseases. Korean J Pediatr. 2013 Sep;56(9):369-376.
Xiao J, et al. Effect of Probiotic Bifidobacterium longum BBS36 in relieving clinical symptoms and modulating plasma cytokine levels of
japanese cedar pollinosis during the pollen season pollinosis during the pollen season controlled trial. J Investig Allergol Clin Immunol
2006; Vol. 16(2): 86-93.
Costa DJ, et al. Efficacy and safety of the probiotic Lactobacillus paracasei LP-33 in allergic rhinitis: a double-blind, randomized, placebo-
-controlled trial. Eur J Clin Nutr. 2014 Feb 26.
Perrin Y, at al. Comparison of two oral probiotic preparations in a randomized crossover trial highlights a potentially beneficial effect of
Lactobacillus paracasei NCC2461 in patients with allergic rhinitis. Clin Transl Allergy. 2014 Jan 6;4(1):1.
Lin WY, et al. Evaluation of the Effect of Lactobacillus paracasei (HF.A00232) in Children (6-13 years old) with Perennial Allergic Rhinitis: A
12-week, Double-blind, Randomized, Placebo-controlled Study. Pediatr Neonatol. 2013 Nov 20.
Lin TY, et al. Effect of probiotics on allergic rhinitis in Df, Dp or dust-sensitive children: a randomized double blind controlled trial. Indian
Pediatr. 2013 Feb;50(2):209-13.
Chen YS, et al. Randomized placebo-controlled trial of lactobacillus on asthmatic children with allergic rhinitis. Pediatr Pulmonol. 2010
Nov;45(11):1111-20.
West CE. Probiotics for allergy prevention. Benef Microbes. 2015 Dec 21:1-10.
Miraglia Del Giudice M, et al. Probiotics and allergic respiratory diseases.J Biol Regul Homeost Agents. 2015 Apr-Jun;29(2 Suppl 1):80-3
Wang IJ, Wang JY. Children with atopic dermatitis show clinical improvement after Lactobacillus exposure. Clin Exp Allergy. 2015
Apr;45(4):779-87.
Enomoto T, et al. Clinical Effects of Apple Polyphenols on Persistent Allergic Rhinitis: A Randomized Double-Blind Placebo-Controlled
Parallel Arm Study. J Investig Allergol Clin Immunol 2006; Vol. 16(5): 283
Mazzone A, et al. Evaluation of Serratia peptidase in acute or chronic inflammation of otorhinolaryngology pathology: a multicentre, dou-
ble-blind, randomized trial versus placebo. J Int Med Res.
(11) 3848.3333
formula-ativa.com.br
@formulaativa online@formula-ativa.com.br